Syngene International Limited (BOM:539268)
India · Delayed Price · Currency is INR 411.70
+45.70 (12.49%)
At close: Oct 28, 2026
Syngene International Market Cap
Syngene International has a market cap or net worth of 163.56 billion as of October 28, 2026. Its market cap has decreased by 37.79% in one year.
Market Cap
163.56B
Enterprise Value
163.33B
Revenue
n/a
Global Rank
n/a
Country Rank
n/a
PE Ratio
88.71
ChartMarket Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 163.56B, an increase of 163.34%. That is a compound annual growth rate of 9.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 163.56B | -36.89% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.17T |
| Divi's Laboratories | 2.40T |
| Zydus Lifesciences | 1.16T |
| Lenskart Solutions | 1.13T |
| Alembic Pharmaceuticals | 150.65B |
| Molbio Diagnostics | 146.76B |
| Indegene | 144.96B |
| Vijaya Diagnostic Centre | 143.76B |